Preparation and anti-tumor activity of paclitaxel silk protein nanoparticles encapsulated by biofilm

References

• Altman GH, Diaz F, Jakuba C, Calabro T, Horan RL, Chen J, Lu H, Richmond J, Kaplan DL. 2003. Silk-based biomaterials [J]. Biomaterials. 24(3):401–416. doi: 10.1016/s0142-9612(02)00353-8.
   PubMed Web of Science ®Google Scholar
• Anbazhagan V, Renganathan R. 2008. Study on the binding of 2,3-diazabicyclo[2.2.2]oct-2-ene with bovine serum albumin by fluorescence spectroscopy [J]. J Lumin. 128(9):1454–1458. doi: 10.1016/j.jlumin.2008.02.004.
   Web of Science ®Google Scholar
• Balmert SC, Little SR. 2012. Biomimetic delivery with micro- and nanoparticles [J]. Adv Mater. 24(28):3757–3778. doi: 10.1002/adma.201200224.
   PubMed Web of Science ®Google Scholar
• Chen H, Huang S, Wang H, Chen X, Zhang H, Xu Y, Fan W, Pan Y, Wen Q, Lin Z, et al. 2021. Preparation and characterization of paclitaxel palmitate albumin nanoparticles with high loading efficacy: an in vitro and in vivo anti-tumor study in mouse models [J]. Drug Deliv. 28(1):1067–1079. doi: 10.1080/10717544.2021.1921078.
   PubMed Web of Science ®Google Scholar
• Dh HS, Sultana R, Prabhu A, SR P, Mohanto S, Subramaniyan V. 2024. Biomedicine and pharmacotherapeutic effectiveness of combinatorial atorvastatin and quercetin on diabetic nephropathy: an in vitro study [J]. Biomed Pharmacother. 174:116533. doi: 10.1016/j.biopha.2024.116533.
   PubMed Web of Science ®Google Scholar
• Duan L, Shirazian S, Habibi Zare M. 2024. Characterization and performance evaluation of pH-sensitive drug delivery of mesoporous silica with honeycomb structure for treatment of cancer [J]. J Mol Liq. 401:124680. doi: 10.1016/j.molliq.2024.124680.
   Web of Science ®Google Scholar
• Endres RG. 2013. Physical principles in sensing and signaling: with an introduction to modeling in biology. Oxford, United Kingdom: Oxford University Press.
   Google Scholar
• Fazli Y, Shariatinia Z. 2017. Controlled release of cefazolin sodium antibiotic drug from electrospun chitosan-polyethylene oxide nanofibrous Mats [J]. Mater Sci Eng C Mater Biol Appl. 71:641–652. doi: 10.1016/j.msec.2016.10.048.
   PubMed Web of Science ®Google Scholar
• Guo X, Li X, Jiang Y, Yi L, Wu Q, Chang H, Diao X, Sun Y, Pan X, Zhou N, et al. 2014. A spectroscopic study on the interaction between p-nitrophenol and bovine serum albumin [J]. J Lumin. 149:353–360. doi: 10.1016/j.jlumin.2014.01.036.
   Web of Science ®Google Scholar
• Hassanzadeh P, Atyabi F, Dinarvand R. 2019. The significance of artificial intelligence in drug delivery system design [J]. Adv Drug Deliv Rev. 151–152:169–190. doi: 10.1016/j.addr.2019.05.001.
   PubMed Web of Science ®Google Scholar
• Hu D, Yuan S, Zhong J, Liu Z, Wang Y, Liu L, Li J, Wen F, Liu J, Zhang J, et al. 2021. Cellular senescence and hematological malignancies: from pathogenesis to therapeutics [J]. Pharmacol Ther. 223:107817. doi: 10.1016/j.pharmthera.2021.107817.
   PubMed Web of Science ®Google Scholar
• Hwang J, Jeong Y, Park JM, Lee KH, Hong JW, Choi J. 2015. Biomimetics: forecasting the future of science, engineering, and medicine [J]. Int J Nanomedicine. 10:5701–5713. doi: 10.2147/IJN.S83642.
   PubMed Web of Science ®Google Scholar
• Kalyane D, Raval N, Maheshwari R, Tambe V, Kalia K, Tekade RK. 2019. Employment of enhanced permeability and retention effect (EPR): Nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer [J]. Mater Sci Eng C Mater Biol Appl. 98:1252–1276. doi: 10.1016/j.msec.2019.01.066.
   PubMed Web of Science ®Google Scholar
• Kantonen SA, Henriksen NM, Gilson MK. 2018. Accounting for apparent deviations between calorimetric and van’t Hoff enthalpies [J]. Biochim Biophys Acta Gen Subj. 1862(3):692–704. doi: 10.1016/j.bbagen.2017.11.020.
   PubMed Web of Science ®Google Scholar
• Lee N-H, You S, Taghizadeh A, Taghizadeh M, Kim HS. 2022. Cell membrane-cloaked nanotherapeutics for targeted drug delivery [J]. Int J Mol Sci. 23(4):23. doi: 10.3390/ijms23042223.
   Web of Science ®Google Scholar
• Li J, Zhang X, Pan L, Lin X, Zhang B, Ren J, Wang Q. 2024. Combinational strategy using albumin-based nanoparticles to enable synergetic anti-rheumatic efficacy and reduced hepatotoxicity [J]. Int J Pharm. 656:124111. doi: 10.1016/j.ijpharm.2024.124111.
   PubMedGoogle Scholar
• Lin M, Li Y, Long H, Lin Y, Zhang Z, Zhan F, Li M, Wu C, Liu Z. 2023. Cell membrane-camouflaged DOX-loaded β-glucan nanoparticles for highly efficient cancer immunochemotherapy [J]. Int J Biol Macromol. 225:873–885. doi: 10.1016/j.ijbiomac.2022.11.152.
   PubMed Web of Science ®Google Scholar
• Lin N, Liu X. 2015. Correction: correlation between hierarchical structure of crystal networks and macroscopic performance of mesoscopic soft materials and engineering principles [J]. Chem Soc Rev. 44(21):7917. doi: 10.1039/c5cs90084k.
   PubMed Web of Science ®Google Scholar
• Liu Q, Zou J, Chen Z, He W, Wu W. 2023. Current research trends of nanomedicines [J]. Acta Pharm Sin B. 13(11):4391–4416. doi: 10.1016/j.apsb.2023.05.018.
   PubMed Web of Science ®Google Scholar
• Liu W, Huang Y. 2022. Cell membrane-engineered nanoparticles for cancer therapy [J]. J Mater Chem B. 10(37):7161–7172. doi: 10.1039/d2tb00709f.
   PubMed Web of Science ®Google Scholar
• Nagaraju PG, S A, Rao PJ, Priyadarshini P. 2024. Assessment of acute and subacute toxicity, pharmacokinetics, and biodistribution of eugenol nanoparticles after oral exposure in Wistar rats [J]. Nanotoxicology. 18(1):87–105. doi: 10.1080/17435390.2024.2314483.
   PubMed Web of Science ®Google Scholar
• Rajendra PKM, Nidamanuri BSS, Swaroop AK, Krishnamurali JS, Balan AP, Selvaraj J, Raman R, Shivakumar HN, Reddy MV, Jawahar N, et al. 2023. Fabrication and in vitro evaluation of silk fibroin-folic acid decorated paclitaxel and hydroxyurea nanostructured lipid carriers for targeting ovarian cancer cells: a double sword approach [J]. J Drug Delivery Sci Technol. 81:104270. doi: 10.1016/j.jddst.2023.104270.
   Web of Science ®Google Scholar
• Ross PD, Subramanian S. 1981. Thermodynamics of protein association reactions: forces contributing to stability [J]. Biochemistry. 20(11):3096–3102. doi: 10.1021/bi00514a017.
   PubMed Web of Science ®Google Scholar
• Shariatinia Z. 2019. Pharmaceutical applications of chitosan [J]. Adv Colloid Interface Sci. 263:131–194. doi: 10.1016/j.cis.2018.11.008.
   PubMed Web of Science ®Google Scholar
• Sofia S, McCarthy MB, Gronowicz G, Kaplan DL. 2001. Functionalized silk-based biomaterials for bone formation [J]. J Biomed Mater Res. 54(1):139–148. doi: 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7.
   PubMed Web of Science ®Google Scholar
• Subia B, Chandra S, Talukdar S, Kundu SC. 2014. Folate conjugated silk fibroin nanocarriers for targeted drug delivery [J]. Integr Biol (Camb). 6(2):203–214. doi: 10.1039/c3ib40184g.
   PubMed Web of Science ®Google Scholar
• Sugarbaker PH, Stuart OA. 2020. HIPEC plus EPIC paclitaxel for maximal perioperative treatments of advanced epithelial ovarian cancer. Long-term results of a pilot study [J]. Surg Oncol. 35:441–446. doi: 10.1016/j.suronc.2020.09.019.
   PubMed Web of Science ®Google Scholar
• Tian Y, Cheng T, Sun F, Zhou Y, Yuan C, Guo Z, Wang Z. 2024. Effect of biophysical properties of tumor extracellular matrix on intratumoral fate of nanoparticles: implications on the design of nanomedicine [J]. Adv Colloid Interface Sci. 326:103124. doi: 10.1016/j.cis.2024.103124.
   PubMed Web of Science ®Google Scholar
• Urbaniak A, Piña-Oviedo S, Yuan Y, Huczyński A, Chambers TC. 2021. Limitations of an ex vivo breast cancer model for studying the mechanism of action of the anticancer drug paclitaxel [J]. Eur J Pharmacol. 891:173780. doi: 10.1016/j.ejphar.2020.173780.
   PubMed Web of Science ®Google Scholar
• Wang H-Y, Zhang Y, Zhang M, Zhang Y-Q. 2024. Functional modification of silk fibroin from silkworms and its application to medical biomaterials: a review [J]. Int J Biol Macromol. 259(Pt 1):129099. doi: 10.1016/j.ijbiomac.2023.129099.
   PubMedGoogle Scholar
• Wang L, Wu Y, Yang N, Yin W, Yang H, Li C, Zhuang Y, Song Z, Cheng X, Shi S, et al. 2024. Self-assembly of maltose-albumin nanoparticles for efficient targeting delivery and therapy in liver cancer [J]. Int J Biol Macromol. 258(Pt 2):128691. doi: 10.1016/j.ijbiomac.2023.128691.
   PubMedGoogle Scholar
• Wang X, Liu Y, He L-L, Liu B, Zhang S-Y, Ye X, Jing J-J, Zhang J-F, Gao M, Wang X, et al. 2015. Spectroscopic investigation on the food components-drug interaction: the influence of flavonoids on the affinity of nifedipine to human serum albumin [J]. Food Chem Toxicol. 78:42–51. doi: 10.1016/j.fct.2015.01.026.
   PubMed Web of Science ®Google Scholar
• Xu J, Song M, Fang Z, Zheng L, Huang X, Liu K. 2023. Applications and challenges of ultra-small particle size nanoparticles in tumor therapy [J]. J Control Release. 353:699–712. doi: 10.1016/j.jconrel.2022.12.028.
   PubMed Web of Science ®Google Scholar
• Xu Z, He Z, Huang J, Qiu W, Cao LNY, Patil A, Yang B-R, Liu XY, Guo W. 2023. Flexible, biocompatible, degradable silk fibroin based display [J]. Chem Engin J. 464:142477. doi: 10.1016/j.cej.2023.142477.
   Web of Science ®Google Scholar
• Yang T, Feng J, Zhang Q, Wu W, Mo H, Huang L, Zhang W. 2020. l-Carnitine conjugated chitosan-stearic acid polymeric micelles for improving the oral bioavailability of paclitaxel [J]. Drug Deliv. 27(1):575–584. doi: 10.1080/10717544.2020.1748762.
   PubMed Web of Science ®Google Scholar
• Yang W, Shao Z, Chen X. 2016. Silk protein nanospheres for paclitaxel/doxorubicin synergistic drug delivery [J]. Nanomed Nanotechnol Biol Med. 12(2):554. doi: 10.1016/j.nano.2015.12.300.
   Web of Science ®Google Scholar
• Yang Y-H, Mao J-W, Tan X-L. 2020. Research progress on the source, production, and anti-cancer mechanisms of paclitaxel [J]. Chin J Nat Med. 18(12):890–897. doi: 10.1016/S1875-5364(20)60032-2.
   PubMed Web of Science ®Google Scholar
• Ying N, Liu S, Zhang M, Cheng J, Luo L, Jiang J, Shi G, Wu S, Ji J, Su H, et al. 2023. Nano delivery system for paclitaxel: recent advances in cancer theranostics [J]. Colloids Surf B Biointerfaces. 228:113419. doi: 10.1016/j.colsurfb.2023.113419.
   PubMed Web of Science ®Google Scholar
• Zinger A. 2023. Unleashing the potential of cell biomimetic nanoparticles: strategies and challenges in their design and fabrication for therapeutic applications [J]. J Control Release. 358:591–600. doi: 10.1016/j.jconrel.2023.04.040.
   PubMed Web of Science ®Google Scholar
• Zou L, Zhang Z, Feng J, Ding W, Li Y, Liang D, Xie T, Li F, Li Y, Chen J, et al. 2022. Paclitaxel-loaded TPGS2k/gelatin-grafted cyclodextrin/hyaluronic acid-grafted cyclodextrin nanoparticles for oral bioavailability and targeting enhancement [J]. J Pharm Sci. 111(6):1776–1784. doi: 10.1016/j.xphs.2022.03.013.
   PubMed Web of Science ®Google Scholar